| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |